NantOmics

Founder / s: Patrick Soon-Shiong
Key people : Steve Benz (President of Genomics), Todd Hembrough (President of Proteomics), Shahrooz Rabizadeh (Chief Scientific Officer) and Patrick Soon-Shiong (CEO & Founder)

NantOmics provides solutions that can detect genomic and proteomic alterations in cancer and identify potential treatment options for the personalized management of patients.

Nantoumics, a member of the NantWorks ecosystem of companies, is a leader in molecular testing and the first company to employ an integrated panomic approach to inform personalized treatment options for patients with cancer. Combining DNA sequencing, RNA sequencing, and quantitative proteomics, NantOmics offers General training capabilities that provide a comprehensive molecular profile of a patient’s cancer. Our proprietary analytical platform proposal molecular diagnostic capabilities that provide actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care.